Section 101 uncertainty not stopping patent filing: financial companies

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Section 101 uncertainty not stopping patent filing: financial companies

Counsel at Capital One, Wells Fargo and the Clearing House Payments Company say they file patents when there is an appropriate business case and only look at patent eligibility requirements as a secondary issue



Section 101 uncertainty is not stopping financial services companies from filing patents at the USPTO, according to in-house counsel at yesterday’s Protecting Innovations in the Financial Services Industry conference in New York.


Giving their personal views, patent lawyers at Wells Fargo, Capital One and the Clearing House Payments Company spoke about how the most important filing consideration is whether there is a clear business case for patent protection, despite the difficulties of getting patents for ‘abstract ideas’ under the post-Alice eligibility framework.

Patent eligibility considerations, they added, have a bigger impact on the decision on how their businesses will go about filing a patent rather than whether they will apply for protection.

“Uncertainty around 101 has changed our filing strategies, but we conduct patentability investigations and much of the time you can build a case on 101 grounds,” said David Easwaran, senior IP counsel at Wells Fargo in New York. “When making the determination on whether to file, we look at whether the business is interested in the technology and whether there is a clear space in the prior art to develop it.”

He adds: “Section 101 influences what we are going to do with a patent application rather than if we are going to file for one.”

Brandon Bludau, senior manager and patent counsel at Capital One, added that he thinks about patent eligibility in the same way.

He explained that it is easy to dismiss patents for some inventions when they are purely business methods and thus very unlikely to be patent eligible. But lots of times, he added, an invention can offer real business value. In those instances, he said, the IP department will look at how the invention is implemented and can change the narrative of claims submitted to emphasise where the innovation lies, to give it a better chance of surviving 101 scrutiny – either at the USPTO or later during an invalidation proceeding. 

Keeping costs down

Spending more time on patent applications to make them 101-rejection-resistant, however, is not cheap. Panellists pointed out that making applications longer and more detailed and going back and forth with patent examiners to explain why a particular invention is patent eligible costs time and money.

Easwaran at Wells Fargo added that it is generally more complicated for him and other attorneys in the financial industry to draft claims, which now have to be more considered. He said that it is important to outline a problem-solution approach in a patent application that is likely to face 101 scrutiny – which is a divergence from the pre-Alice era when the industry generally did not outline the invention’s real world benefits.

“Doing this will make a patent more likely to stand up because courts like to see the features and benefits of an invention,” he said. “There is an expectation that more detail will help to combat a 101 assault.”

Sean Reilly, associate general counsel at the Clearing House Payments Company, a payment system infrastructure, said he has similarly found that putting more meat on the bones of a disclosure is important for fighting off 101 rejections. That need also puts more pressure on outside counsel to draft applications correctly, he added.

Bludau at Capital One said he was becoming more concerned with the cost of prosecution because of the need for financial services companies to put more into their applications.

Trade secrets v patents

With the growing uncertainty surrounding Section 101 and the resulting rise in prosecution costs, panellists pointed out that trade secrets might start to become a more popular form of protection in the financial services industry.

Charley Macedo, partner at Amster, Rothstein & Ebenstein, pointed out that a popular argument for why fintech innovations should be patent eligible is that protection encourages organisations to disclose their inventions rather than keep them confidential.

There was concern among some panellists that relying too heavily on trade secrets would be counterproductive unless the business was confident that it could treat all of its confidential inventions with the quality of secrecy.

“I think about trade secrets and obviously one concern with that route is whether they will stay secret,” said Easwaran. “It is very easy for businesses to say they will keep inventions secret and then really not do anything to keep them as such.”

He added that trade secrets are preferable to patent protection in instances where there is a strong 101 case against approving an invention, there is little value to be gained in disclosing an invention or if it will be too difficult to enforce the patent. 

Bludau said he will similarly look to see if something could qualify for trade secret protection and whether it would be considered patent eligible by the patent office and the courts. 

Reilly pointed out that there will always be areas of technology that will benefit more from trade secret status than from patent protection. But ultimately, he added, there has been an uptick in patenting in the financial space and a move towards using open source technologies that cannot be kept secret.

more from across site and SHARED ros bottom lb

More from across our site

María Aurora García of Berken IP explains how intellectual property rights holders can use customs monitoring and online enforcement tools to identify parallel imports and support compliance with consumer protection rules
The Jakarta-based firm says personal networks and a distinctive strategy can help it guide foreign clients through what can be a tricky IP landscape
Munich litigation boutique formed by former Taylor Wessing partners continues expansion as it seeks to cement its position in the UPC market
Yvonne Tang and Siau Wen Lim, the second and third IP specialists to sit on the firm’s management committee, say IP is ‘uniquely positioned’ to support cross-practice work
As competing firms come under common ownership, clients may care less about formal conflicts and more about how openly firms discuss them
Facing increased lateral movement and in-house competition, firms are investing in flexible billing hours and tailored career progression to improve associate retention
As the US reflects on 250 years of independence, patent lawyers say innovation is reshaping old hiring priorities, with firms seeking broader IP expertise over specialisation
The Nokia v Acer ruling in the UK suggests arbitration is moving from the sidelines towards the mainstream of global FRAND disputes - and could reshape forum strategy in the process
The Life Sciences Awards is thrilled to present the shortlist for the 2026 Americas Awards
From Türkiye to Poland and Nigeria, firms with deep local roots continue to dominate the top tier, proving that market expertise can outweigh international scale in many CEE, Middle Eastern and African jurisdictions
Gift this article